Congratulations! Huayi Pharmaceuticals was listed on Top 50 Fast Growing Pharmaceuticals Enterprise!

The Press Conference of Most Influential List of China’s Pharmaceutical Industry in 2019 and the 13th China Pharmaceutical Industry Development Summit Forum hosted by the All-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce was held in Nanchang Shangri-La Hotel on August 6th-8th, 2020.

The Conference with the theme of “Information, Responsibility, Innovation, Breakthrough”, released a total of 10 lists including the Top 100 Chinese Pharmaceutical Enterprises in 2019, Top 50 Fast Growing Pharmaceutical Enterprises etc.. Li Zhaoqian, member and vice chairman of the All-China Federation of Industry and Commerce, Zhang Boli, academician of the Chinese Academy of Engineering, President of Tianjin University of Traditional Chinese Medicine, Yao Jingyuan, special researcher of the Counselor Office of the State Council, Zhang Wenzhou, former deputy director of the State Food and Drug Administration, Li Daning, former deputy director of the State Administration of Traditional Chinese Medicine and other well-known domestic experts, leaders of the Jiangxi Provincial Government and leaders of Nanchang City are invited to attend the 13th China Pharmaceutical Industry Development Summit Forum in 2020 to discuss the current development situation of the pharmaceutical industry, directly point out the industry problems and how China’s pharmaceutical industry can seize opportunities and innovate.

Huayi Pharmaceuticals (Anhui) Co., Ltd. adheres to the corporate values of “creating quality with responsibility and seeking win-win with quality”, and always insists on realizing efficient, high-quality, cost-controllable generic drug R&D and production services for customers. Since 2018, the company has comprehensively adjusted its strategic development policy and actively explored the domestic market. As an emerging force in the domestic market, the company is not only in a period of rapid growth and development, but also has a mature technical team and operating model. It has won the “Top 50 Fast Growing Pharmaceuticals Enterprises” title in the China Pharmaceutical Industry’s Most Influential List Conference!


This award is the industry’s high affirmation and recognition of Huayi Pharmaceuticals, which will greatly enhance the confidence in the development of the company. In the future, we will not forget our original intention, and continue to make new contributions to the medical and health industry with professional technology, dedicated attitude, and honest quality.

Huayi sincerely looks forward to establishing diversified cooperative relationships with domestic and foreign partners in the fields of pharmaceutical R&D, product transfer and generic drug consistency evaluation services, phase I clinical trials, biological sample analysis and testing, etc., to jointly develop international and domestic pharmaceutical markets. Steady progress from a higher starting point.